J. Goldman & Co’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,202,375
Closed -$13M 884
2026
Q1
$13M Sell
1,202,375
-288,850
-19% -$2.47M 0.38% 74
2025
Q4
$9.11M Buy
+1,491,225
New +$8.9M 0.24% 117
2025
Q1
Sell
-151,900
Closed -$1.25M 597
2024
Q4
$1.25M Buy
+151,900
New +$1.22M 0.03% 307
2022
Q2
Sell
-110,864
Closed -$1.72M 441
2022
Q1
$1.72M Buy
110,864
+72,741
+191% +$918K 0.08% 210
2021
Q4
$322K Buy
+38,123
New +$329K 0.02% 300
2014
Q4
Sell
-416,000
Closed -$13.5M 262
2014
Q3
$13.5M Buy
+416,000
New +$14.1M 0.82% 18
2014
Q1
Sell
-125,000
Closed -$3.17M 286
2013
Q4
$3.17M Sell
125,000
-285,000
-70% -$6.82M 0.4% 79
2013
Q3
$8.77M Buy
+410,000
New +$8.42M 0.82% 24

Other funds holding PTEN

J. Goldman & Co's PTEN Position: Q2 2026 in Review

J. Goldman & Co sold out of Patterson-UTI (PTEN) in Q2 2026, closing a stake of 1,202,375 shares — an estimated $13M sold.

J. Goldman & Co first reported a position in PTEN in Q3 2013 and held it in 8 quarters. The position peaked at $13.5M in Q3 2014. 438 funds tracked by Wall St. Rank hold PTEN as of Q2 2026.

  • J. Goldman & Co reported no remaining Patterson-UTI position as of Q2 2026 after selling out during the quarter.
  • J. Goldman & Co sold 1,202,375 Patterson-UTI shares in Q2 2026, an estimated $13M.
  • J. Goldman & Co first reported a position in Patterson-UTI in Q3 2013 and held it in 8 quarters.
  • J. Goldman & Co's Patterson-UTI position peaked at $13.5M in Q3 2014.
  • 438 funds tracked by Wall St. Rank held Patterson-UTI as of Q2 2026.

Based on J. Goldman & Co's 13F filing for Q2 2026, filed 14 Aug 2026.